Clinical Effect and Prognosis Evaluation of Radiofrequency Ablation Combined with Lenvatinib Targeted Therapy for Primary Hepatocellular Carcinoma

ZHAO Shuai

doi:10.3969/j.issn.1672-7185.2022.07.014

Home>Articles>Clinical Effect and Prognosis Evaluation of Radiofrequency Ablation Combined with Lenvatinib Targeted Therapy for Primary Hepatocellular Carcinoma

DOI: 10.3969/j.issn.1672-7185.2022.07.014

Clinical Effect and Prognosis Evaluation of Radiofrequency Ablation Combined with Lenvatinib Targeted Therapy for Primary Hepatocellular Carcinoma

ZHAO Shuai

Machine-generated Keywords：

Publication Date：2022-07-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 38-41,45 )

Chinese Practical Journal of Rural Doctor

ISSN：1672-7185

Year, Vol.(Issue)：2022,29(7)